This study compared the need for more intense treatment and administrative interactions following the use of the branded extended release minocycline versus the generic twice daily formulation.
Gupta, Preeta et al.
Journal of the American Academy of Dermatology , Volume 76 , Issue 6 , 1195 – 1197
Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.